BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1360 related articles for article (PubMed ID: 23899562)

  • 1. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
    Chapman K; Holmes M; Seckl J
    Physiol Rev; 2013 Jul; 93(3):1139-206. PubMed ID: 23899562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions.
    Diaz R; Brown RW; Seckl JR
    J Neurosci; 1998 Apr; 18(7):2570-80. PubMed ID: 9502816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 11beta-hydroxysteroid dehydrogenases in the brain.
    Holmes MC; Seckl JR
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):9-14. PubMed ID: 16413106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.
    Seckl JR; Walker BR
    Endocrinology; 2001 Apr; 142(4):1371-6. PubMed ID: 11250914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation.
    Seckl J
    J Intern Med; 2024 Jan; 295(1):20-37. PubMed ID: 37941106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
    Seckl JR
    Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.
    Krozowski Z; Li KX; Koyama K; Smith RE; Obeyesekere VR; Stein-Oakley A; Sasano H; Coulter C; Cole T; Sheppard KE
    J Steroid Biochem Mol Biol; 1999; 69(1-6):391-401. PubMed ID: 10419017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system.
    Seckl JR; Chapman KE
    Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ.
    Beck KR; Inderbinen SG; Kanagaratnam S; Kratschmar DV; Jetten AM; Yamaguchi H; Odermatt A
    J Lipid Res; 2019 Sep; 60(9):1535-1546. PubMed ID: 31273032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
    Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.
    Wyrwoll CS; Holmes MC; Seckl JR
    Front Neuroendocrinol; 2011 Aug; 32(3):265-86. PubMed ID: 21144857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymology and molecular biology of glucocorticoid metabolism in humans.
    Blum A; Maser E
    Prog Nucleic Acid Res Mol Biol; 2003; 75():173-216. PubMed ID: 14604013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
    Frey FJ; Odermatt A; Frey BM
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 11beta-hydroxysteroid dehydrogenases: functions and physiological effects.
    Krozowski Z
    Mol Cell Endocrinol; 1999 May; 151(1-2):121-7. PubMed ID: 10411326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
    Morris DJ; Brem AS; Odermatt A
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons.
    Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K
    J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
    Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
    Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.